Why cancer screening should become more like heart disease prevention. You’re reading The Checkup With Dr. Wen, a newsletter ...

AI is changing how cancer care decisions are made, empowering patients and doctors to make more personalized choices. For ...

In conversation with THE WEEK, Dr Sewanti Limaye, Director of Medical & Precision Oncology at Sir H.N. Reliance Foundation Hospital, emphasised that personalised oncology is the future of cancer ...

Oncologists say there is promise in new AI tools that can guide them when choosing between two plausible treatments.

Genetic ancestry may play a key role in how acral melanoma, a rare and aggressive type of skin cancer, develops and behaves, ...

Resistant cells demonstrated global decreases in DNA accessibility with localized opening at resistance-driving loci, indicating non-mutational epigenetic reprogramming rather than canonical oncogenic ...

Cancer cannot be explained by mutations alone. Today, cancer is understood as a multifactorial disease, shaped by genetics, ...

The recipient of the inaugural global research grant will harness AI to uncover insights that could result in more personalized care for women diagnosed with ovarian cancer. TORONTO, Feb. 19, 2026 / ...

Experts discuss how treatment strategies for NSCLC differ between resectable and metastatic disease, emphasizing a multimodal, curative approach in early-stage cancer versus personalized systemic ...

In response to the challenges, some insurers have begun expanding care coordination, cost transparency tools and nurse-led support programs which are aimed at helping patients navigate care more ...

A newer type of prostate cancer scan called 64 Cu-SAR-bisPSMA found more than twice as many cancer spots as a commonly used PSMA PET scan in men whose prostate-specific antigen (PSA) was rising after ...

Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.